| 000 | 01378 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513083948.0 | ||
| 264 | 0 | _c19960221 | |
| 008 | 199602s 0 0 eng d | ||
| 022 | _a1062-8401 | ||
| 024 | 7 |
_a10.1089/cbr.1995.10.195 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuida, M | |
| 245 | 0 | 0 |
_aLong-term subcutaneous recombinant interleukin-2 as maintenance therapy: biological effects and clinical implications. _h[electronic resource] |
| 260 |
_bCancer biotherapy _c1995 |
||
| 300 |
_a195-203 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aInterleukin-2 _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aRemission Induction |
| 700 | 1 | _aAbbate, I | |
| 700 | 1 | _aCasamassima, A | |
| 700 | 1 | _aMusci, M D | |
| 700 | 1 | _aLatorre, A | |
| 700 | 1 | _aLorusso, V | |
| 700 | 1 | _aCorreale, M | |
| 700 | 1 | _aDe Lena, M | |
| 773 | 0 |
_tCancer biotherapy _gvol. 10 _gno. 3 _gp. 195-203 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/cbr.1995.10.195 _zAvailable from publisher's website |
| 999 |
_c8547043 _d8547043 |
||